Drug: estrace Quarter: 2016Q3
Total Drug/Injury Combinations: 30 Number of Pages: 2
DRUGNAME | PT | EventCount | |
---|---|---|---|
ESTRACE | Vulvovaginal discomfort | 2 | view events |
ESTRACE | Adrenal disorder | 1 | view events |
ESTRACE | Application site discharge | 1 | view events |
ESTRACE | Blood glucose increased | 1 | view events |
ESTRACE | Blood pressure increased | 1 | view events |
ESTRACE | Breast mass | 1 | view events |
ESTRACE | Colorectal cancer stage I | 1 | view events |
ESTRACE | Contraindicated product administered | 1 | view events |
ESTRACE | Device difficult to use | 1 | view events |
ESTRACE | Diarrhoea | 1 | view events |
ESTRACE | Drug effect decreased | 1 | view events |
ESTRACE | Drug ineffective for unapproved indication | 1 | view events |
ESTRACE | Ear disorder | 1 | view events |
ESTRACE | Epinephrine increased | 1 | view events |
ESTRACE | Feeling hot | 1 | view events |
ESTRACE | Fungal infection | 1 | view events |
ESTRACE | Headache | 1 | view events |
ESTRACE | Hospitalisation | 1 | view events |
ESTRACE | Intentional product misuse | 1 | view events |
ESTRACE | Mammogram abnormal | 1 | view events |
Total Drug/Injury Combinations: 30 Number of Pages: 2
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)